T1	intervention 24 45	adjuvant chemotherapy
T4	outcome 1174 1188	10 to 13 years
T5	iv-bin-percent 1153 1155	5%
T6	cv-bin-percent 1158 1160	7%
T7	iv-bin-percent 1201 1203	3%
T8	cv-bin-percent 1206 1208	0%
T9	outcome 1261 1270	mean LVEF
T10	iv-bin-percent 1362 1367	64.8%
T11	cv-bin-percent 1370 1375	61.4%
T12	total-participants 739 742	180
T13	eligibility 743 766	breast cancer survivors
T15	outcome 1496 1500	LVEF
T3	outcome 1011 1029	LVEF less than 50%
T16	outcome 1030 1039	at 5 to 8
T17	control 487 506	without doxorubicin
